Forty-6 patients refused to take part, and two patients experienced other forms of cancers . Therefore, of the 256 eligible patients, read review31 were being excluded. In complete, efficient responses ended up received from 225 sufferers in this review.The demographic, medical and psychological variables were being explained with median, mean, normal deviation , variety and share as ideal. In this analyze, groups for which the reaction rate was significantly less than five% ended up blended for the categorical variables as there were only 7 individuals who had not acquired chemotherapy, this group was put together with the ‘‘inductive therapy” group. The P-P-plot and K-S assessments were being applied to verify the regular distribution of steady variables. Pearson’s chi-square take a look at was applied to review distinctions in categorical variables. Pearson’s correlation was used to look at correlations between continuous variables. Information which includes F price, R2, R2-changes , standardized regression coefficient and P worth for each move in the regression design were being claimed. Furthermore, multi-collinearity was checked by tolerance and variance inflation factor . All analyses had been conducted using SPSS for Home windows, Ver. 13., with two-tailed likelihood worth of < 0.05 considered to be statistically significant. Univariate analyses failed to find any significant associations of demographic and clinical variables with PTSD symptoms. Age and gender were considered as control variables and added to Block 1. As shown in Table 4, PSS was significantly and negatively associated with PTSD symptoms , and it accounted for 6.4% of the variance in the prediction of PTSD symptoms in Block 2. However, only optimism showed a significant and negative association with PTSD symptoms . Tolerance and VIF indicated that multi-collinearity could be accepted in the regression model. Women were more vulnerable to PTSD symptoms than men . In the present study on PTSD symptoms in patients with hematological malignancies, based upon the scoring method , 10.7% of our sample reported PTSD symptoms. Using the same diagnostic tool and conservative cutoff score, cancer-related PTSD prevalence was determined in the range between 1.9% and 12% in previous studies of patients with breast cancers, which decreased over time since diagnosis or treatment. The prevalence of PTSD symptoms in our sample was similar to that in recently diagnosed and treated cancers patients, but higher than that of patients with gynecologic cancer in China. Using the Posttraumatic Diagnostic Scale , 13% of the Hodgkin’s lymphoma survivors were diagnosed with PTSD. The bias-adjusted prevalence of PTSD was similar using the cutoff score ≥ 44 of PCL-C and symptom cluster methods in long-term non-Hodgkin’s lymphoma survivors. Fifty-four of the 200 acute leukemia participants who scored ≥ 40 on the Stanford Acute Stress Reaction Questionnaire demonstrated PTSD. In fact, based upon the results of currently available studies, clear and reasonable comparisons with the present study could not be carried out, because the knowledge about PTSD in hematological malignancies is relatively limited to our best knowledge, and there were differences in the measurement tools and diagnostic methods used across studies.